MacroGenics financials at a glance

+ Portfolio

The revenue of MacroGenics is reported as 0.05875 billion Dollars in the fiscal year 2023. The earnings were -2.58 Dollars per share in 2023, which was 32.31 lower than 2022. And about -0.07997 billion Dollars are reported as free cash flow in the financials of MacroGenics 2023. No dividends were paid to the shareholders of the MacroGenics stock NasdaqGS:MGNX in the financial year 2023.

$58.75M

Revenue

$-2.58

Earnings Per Share

-,197.55%

Gross Margin %

$-20.76M

Free Cash Flow

Revenue

58.75

Earnings Per Share

-2.58

Gross Margin %

-,197.55

Free Cash Flow

-20.76

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Rev.	Revenue	N/A	$58.75M	$151.94M	$77.45M	$104.88M	$64.19M	$60.12M	$157.74M	$91.88M	$100.85M	$47.80M	$58.04M
GM %	Gross Margin %	-78.53%	-,197.55%	-41.11%	-,180.49%	-84.21%	-,204.28%	-,217.40%	6.66%	-32.88%	2.56%	-46.84%	19.73%
OM	Operating Margin	-88.26%	-,286.38%	-79.91%	-,261.85%	-,124.96%	-,276.04%	-,284.77%	-14.04%	-65.35%	-20.01%	-80.16%	0.63%
EPS	Earnings Per Share	$0.81	$-2.58	$-1.95	$-3.37	$-2.47	$-3.16	$-4.19	$-0.54	$-1.69	$-0.63	$-1.40	$-0.04
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%
Sha.	Shares	N/AM	62.43M	61.84M	61.32M	56.26M	48.98M	48.78M	36.92M	34.97M	34.53M	29.97M	27.47M
OCF	Operating Cash Flow	N/A	$-78.21M	$-86.96M	$-,143.83M	$-,111.90M	$-,137.15M	$-,153.23M	$14.41M	$-43.68M	$-13.66M	$-32.76M	$-14.17M
FCF	Free Cash Flow	N/A	$-20.76M	$-90.58M	$-,150.03M	$-,117.80M	$-,141.44M	$-,285.98M	$-14.99M	$-55.06M	$-22.86M	$-36.33M	$-17.13M
FCFS	Free Cash Flow Per Share	$-0.36	$-1.29	$-1.47	$-2.50	$-2.25	$-2.88	$-4.35	$-0.42	$-1.59	$-0.72	$-1.33	$-2.50

MacroGenics financials at a glance

Financials

Discover